India’s first vaccine for cervical cancer launchedOctober 20th, 2008 - 7:21 pm ICT by IANS
Kolkata, Oct 20 (IANS) MSD Pharmaceuticals India, part of US pharma giant Merck & Co, Monday launched India’s first vaccine to help prevent cervical cancer.”Cervical cancer is the most common cancer among women in India, well ahead of breast cancer,” said Anjana Narain, MSD’s director vaccine, during the launch here.
The vaccine, Gardasil, was launched in the US in 2006.
In India, each dose of the vaccine will cost Rs.2,800, and one needs to take three doses.
Narain said low awareness of this type of cancer is the sole cause behind high mortality rate among women.
“Every year, there are 132,000 new cases of cervical cancer in India and 74,000 women die every year because of it,” she said.
- Vaccination can prevent cervical cancer deaths: Experts - Aug 07, 2012
- Bollywood, fashion world unite against cervical cancer - Jul 01, 2012
- Sanitary napkins can reduce cervical cancer risk: Survey - Feb 08, 2011
- Brinda questions cervical cancer vaccines programme - Apr 08, 2010
- 132,000 new cervical cancer cases every year: Chavan - Mar 26, 2010
- Tobacco major cause of cancer deaths: Study - Apr 02, 2012
- Cervical cancer leading cancer-killer among Indian women - Mar 28, 2012
- 'Indian infants make 25 percent of global diarrhea deaths' - Mar 09, 2011
- Cervical cancer vaccine should be cheaper: Nobel laureate - Dec 02, 2009
- Cancer vaccine kicks up controversy in India - Dec 30, 2008
- Sleeping pills cause higher death risk - Feb 28, 2012
- Panel report on HPV vaccine trials slammed - May 09, 2011
- India capable of producing lower-cost HPV vaccine - Jul 10, 2010
- Twin viruses linked to prostate cancer - Aug 03, 2012
- By 2020, breast cancer to overtake cervical cancer in India - Aug 17, 2010